EGFR and HER2 Expression in Papillary Thyroid Carcinoma
활용도 Analysis
논문 Analysis
연구자 Analysis
저자
김용석
김정수
김용석
제어번호
105962631
학술지명
The Koreran journal of Endocrine Surgery
권호사항
Vol.
18
No.
4
[
2018
]
발행처
대한갑상선-내분비외과학회
자료유형
학술저널
수록면
228-235
언어
English
출판년도
2018
등재정보
KCI등재
판매처
'
EGFR and HER2 Expression in Papillary Thyroid Carcinoma' 의 참고문헌
Worldwide increasing incidence of thyroid cancer : update on epidemiology and risk factors
Thyroid cancer epidemiology and prognostic variables
The prevalence and prognostic value of BRAF mutation in thyroid cancer
The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy
Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma
Prognostic significance of Ki-67 labeling index in papillary thyroid carcinoma
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma
Ki-67: Level of evidence and methodological considerations for its role in the clinical management of breast cancer: Analytical and critical review
Increasing incidence of thyroid cancer in the United States, 1973-2002
High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma
Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas
Expression of phosphatase and tensin homolog, epidermal growth factor receptor, and Ki-67 in astrocytoma: a prospective study in a tertiary care hospital
Epidermal growth factor receptors: a functional perspective
Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma
Epidermal growth factor receptor dependence in human tumors: more than just expression
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
EGFR and cancer prognosis
Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid
Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland
Comparative study on overexpression of HER2/neu and HER3 in gastric cancer
Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAFV600E mutation
Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma
BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications
Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer
Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
'
EGFR and HER2 Expression in Papillary Thyroid Carcinoma'
의 유사주제(
) 논문